Disitertide
CAS No. 272105-42-7
Disitertide( P144 | P144 Peptide )
Catalog No. M13832 CAS No. 272105-42-7
Disitertide (P144) is a TGF-β1 antagonist peptide.
Disitertide (P144) is a TGF-β1 antagonist peptide.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 351 | In Stock |
|
10MG | 597 | In Stock |
|
25MG | 1269 | In Stock |
|
100MG | Get Quote | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameDisitertide
-
NoteResearch use only, not for human use.
-
Brief DescriptionDisitertide (P144) is a TGF-β1 antagonist peptide.
-
DescriptionDisitertide (P144) is a TGF-β1 antagonist peptide; induces apoptosis in GBM cell lines and reduces SMAD2 phosphorylation with downregulation of SKI and an upregulation of SMAD7 at both transcriptional and translational levels; active in vivo.Brain Cancer Phase 2 Clinical
-
In VitroDisitertide (P144, 100 μg/mL) suppresses the protein expression levels of PI3K and p-Akt, and induce the protein expression of Bax in MC3T3-E1 cells. Disitertide (TGF-β1 inhibitor) abrogates the MACC1- AS1 expression in GC cells, suggesting that targeting TGFβ signaling pathway may be a potential strategy to inhibit MSC-induced stemness and chemoresistance.Disitertide (10 μg/mL to 200 μg/mL) affects proliferation, induces apoptosis as well as anoikis in A172 and U-87 MG GBM cell lines.Western Blot AnalysisCell Line:Mouse embryo osteoblast precursor MC3T3-E1 cells Concentration:100 μg/mL Incubation Time:4 h Result:Significantly suppressed the protein expression levels of PI3K and p-Akt, and induce the protein expression of Bax in MC3T3-E1 cells compared with the miR-590 group
-
In VivoDisitertide (Topical application, 300 μg/mL) may promote scar maturation and improvement of hypertrophic scar morphology features in an “in vivo” model in nude mice after two weeks of treatment. Animal Model:Human hypertrophic scars were implanted in 60 nude mice. Dosage:300 μg/mL was added the Lipogel.Administration:Topical application daily administered.Result:Successful shedding was achieved in 83,3% of the xenografts.
-
SynonymsP144 | P144 Peptide
-
PathwayCancer
-
TargetBrain Cancer
-
RecptorTGFBR
-
Research AreaCancer
-
IndicationBrain Cancer
Chemical Information
-
CAS Number272105-42-7
-
Formula Weight1580.824
-
Molecular FormulaC68H109N17O22S2
-
Purity>98% (HPLC)
-
SolubilityDMSO
-
SMILESCCC(C)C(C(=O)NC(C(C)CC)C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(C)C(=O)NC(CCSC)C(=O)NC(CCSC)C(=O)NC(CCC(=O)N)C(=O)NC(CC(=O)N)C(=O)O)NC(=O)C(CO)NC(=O)C(C)NC(=O)C(CC(=O)O)NC(=O)C(CC(C)C)NC(=O)C(CO)NC(=O)C(C(C)O)N
-
Chemical NameL-Asparagine, L-threonyl-L-seryl-L-leucyl-L-α-aspartyl-L-alanyl-L-seryl-L-isoleucyl-L-isoleucyl-L-tryptophyl-L-alanyl-L-methionyl-L-methionyl-L-glutaminyl-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Gallo-Oller G, et al. Cancer Lett. 2016 Oct 10;381(1):67-75.
2. Baltanas A, et al. Antioxid Redox Signal. 2013 Nov 10;19(14):1607-18.
3. Diaz-Valdes N, et al. Cancer Res. 2011 Feb 1;71(3):812-21.
molnova catalog
related products
-
MK-4101
A novel potent, orally bioavailable and brain penetrating Hedgehog pathway (Hh) inhibitor that inhibits Smoothened (Smo) with IC50 of 1.1 uM.
-
GDC-0084
A potent, selective, brain penetrant dual inhibitor of class I PI3Ks and mTOR with Ki of 2/46/3/10/70 nM for PI3Kα/β/δ/γ/mTOR, respectively.
-
Perifosine
A oral bioavailable alkylphospholipid that displays significant antiproliferative activity in vitro and in vivo in several human tumor model; acts as an Akt inhibitor and a PI3K inhibitor.